Retrospective cohort study evaluates treatment patterns and impact in secondary progressive multiple sclerosis, highlighting significant outcomes for patients.
To evaluate the real-world clinical and economic impact and treatment patterns in people with secondary progressive multiple sclerosis (SPMS) in the United States (US).
No takes yet. Share an insight, caveat, or question.
Greene et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: